Global Plasma Blood Collection Tube Market Size By Type (Manual Blood Collection, Automated Blood Collection), By Application (Hospitals and Pathology Laboratories, Blood Banks), By Region, And Segmen...

The Global Plasma Blood Collection Tube Market was valued at USD 2.4 billion in 2023 and is projected to reach USD 4.1 billion by 2031, growing at a CAGR of 6.9% during the forecast period from 2023 to 2031. This growth is driven by the rising demand for diagnostic testing, an increase in chronic disease prevalence, and a surge in healthcare infrastructure development across emerging markets. Plasma blood collection tubes, essential for coagulation, serology, and immunohematology testing, are gaining traction due to their effectiveness in preserving plasma quality for analysis. Technological advancements in blood collection systems and growing awareness about early diagnosis are further accelerating market expansion.

Drivers:

1. Increasing Diagnostic Testing Volume:

The global rise in diagnostic procedures, fueled by chronic diseases such as cancer, diabetes, and cardiovascular conditions, is significantly boosting the demand for plasma blood collection tubes.

2. Expansion of Healthcare Infrastructure:

Emerging economies are investing heavily in healthcare infrastructure, including clinical laboratories and diagnostic centers, fostering the adoption of advanced blood collection tools.

3. Technological Advancements in Collection Tubes:

Innovations like vacuum-based and sterile tubes, along with improved additive technologies (e.g., anticoagulants like EDTA or citrate), enhance accuracy and sample integrity.

Restraints:

1. High Cost of Advanced Blood Collection Products:

Premium blood collection tubes with specialized features can be cost-prohibitive, especially in underfunded healthcare systems, limiting widespread adoption.

2. Risk of Contamination and Handling Errors:

Despite automation, manual handling in some setups poses contamination risks, affecting diagnostic accuracy and limiting trust in test results.

Opportunity:

1. Rising Demand in Point-of-Care Diagnostics and Home Sampling:

The shift toward decentralized diagnostics and remote patient monitoring opens new opportunities for portable and user-friendly plasma blood collection tubes.

2. Growth in Clinical Research and Biobanking:

Expanding clinical trials and biobank projects require large-scale, high-quality blood samples, positioning plasma tubes as critical tools in sample collection.

Market by System Type Insights:

Vacuum Blood Collection Tubes emerged as the dominant system type in 2023, accounting for the largest market share. These tubes offer superior sample integrity, reduced contamination risk, and ease of use in both manual and automated settings. Non-vacuum tubes remain in use but are expected to see slower growth due to manual operation limitations.

Market by End-use Insights:

Hospitals and Diagnostic Laboratories collectively accounted for over 70% of the market share in 2023. Hospitals are primary users due to their extensive testing operations, while diagnostic labs rely heavily on efficient blood collection for accurate results. Biobanks and Research Institutions are anticipated to exhibit the fastest growth during the forecast period, driven by their demand for high-fidelity plasma samples.

Market by Regional Insights:

North America led the global market in 2023 due to its advanced healthcare infrastructure, high diagnostic awareness, and significant investment in laboratory automation. Asia-Pacific is poised for the highest growth rate through 2031, driven by expanding medical tourism, healthcare investments, and growing awareness in countries like China, India, and South Korea. Europe also holds a strong share, supported by established clinical laboratory networks and favorable reimbursement policies.

Competitive Scenario:

Key players in the Global Plasma Blood Collection Tube Market include:

Becton, Dickinson and Company (BD)

Greiner Bio-One International GmbH

Thermo Fisher Scientific Inc.

Terumo Corporation

Sarstedt AG & Co. KG

FL MEDICAL s.r.l.

Cardinal Health

Narang Medical Ltd.

Medtronic

Kabe Labortechnik GmbH

Companies are investing in automation-friendly designs, expanding production capacity, and partnering with healthcare providers to enhance market reach.

Scope of Work – Global Plasma Blood Collection Tube Market

Report Metric Details

Market Size (2023) USD 2.4 billion

Projected Market Size (2031) USD 4.1 billion

CAGR (2023–2031) 6.9%

Market Segments By System Type (Vacuum, Non-Vacuum); By End-Use (Hospitals, Diagnostics Labs, Research Centers); By Region

Growth Drivers Rise in diagnostic procedures, chronic disease burden, automation in labs

Opportunities Expansion in home-based sampling and biobanking applications

Key Market Developments:

2023: Becton, Dickinson and Company launched its next-gen vacuum plasma tubes integrated with barcode automation, improving workflow efficiency.

2024: Thermo Fisher Scientific expanded its blood collection product line for research labs, featuring improved sample stability and volume indicators.

2025: Greiner Bio-One partnered with a European diagnostics group to deliver sustainable and recyclable blood collection solutions in hospital settings.

FAQs:

1) What is the current market size of the Global Plasma Blood Collection Tube Market?

The market size was valued at USD 2.4 billion in 2023.

2) What is the major growth driver of the Global Plasma Blood Collection Tube Market?

The increasing demand for diagnostic testing and rising chronic disease incidence are key growth drivers.

3) Which is the largest region during the forecast period in the Global Plasma Blood Collection Tube Market?

North America holds the largest share, while Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in the Global Plasma Blood Collection Tube Market?

The Vacuum Blood Collection Tube segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Plasma Blood Collection Tube Market?

Key players include BD, Thermo Fisher Scientific, Greiner Bio-One, Terumo, and Sarstedt AG.